MASH Therapies: Approved Drug or Real-World Data

Nov 09 2025
Convention Center: Ballroom A, Level 3
5:00 PM - 6:30 PM

World Class Speakers

Robert M Wilechansky, MD
Moderator

Robert M Wilechansky, MD

Oregon Health & Science University
Philip N Newsome, MD, PhD
Moderator

Philip N Newsome, MD, PhD

King's College London

Journey Maps

Objectives

  • Review efficacy and safety data from ongoing clinical trials of approved drugs for MASH, highlighting emerging evidence and remaining gaps.
  • Discuss challenges and insights from implementing approved MASH treatmentsas well as weight loss medications, bariatric surgeries, and endoscopic proceduresin routine clinical practice, including patient selection and monitoring.